Titan Common Stock Total Equity from 2010 to 2024
| TTNP Stock | USD 6.94 0.42 6.44% |
Common Stock Total Equity | First Reported 1999-06-30 | Previous Quarter 10 K | Current Value 10 K | Quarterly Volatility 96 M |
Check Titan Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Titan Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 106.4 K, Interest Expense of 31.7 K or Total Revenue of 174.8 K, as well as many indicators such as Price To Sales Ratio of 32.03, Dividend Yield of 0.0 or PTB Ratio of 0.89. Titan financial statements analysis is a perfect complement when working with Titan Pharmaceuticals Valuation or Volatility modules.
Titan | Common Stock Total Equity |
Latest Titan Pharmaceuticals' Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Titan Pharmaceuticals over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Titan Pharmaceuticals' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Titan Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Titan Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 139,229,619 | |
| Geometric Mean | 2,203,569 | |
| Coefficient Of Variation | 102.69 | |
| Mean Deviation | 135,337,822 | |
| Median | 98,700,000 | |
| Standard Deviation | 142,973,306 | |
| Sample Variance | 20441.4T | |
| Range | 297.8M | |
| R-Value | (0.72) | |
| Mean Square Error | 10555.5T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (23,064,980) | |
| Total Sum of Squares | 286179.1T |
Titan Common Stock Total Equity History
About Titan Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Titan Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Titan Pharmaceuticals investors use historical funamental indicators, such as Titan Pharmaceuticals's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Titan Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Titan Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Titan Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Titan Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Titan Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 6.3 K | 6 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.